At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biomarker Identification to Predict the Evolution of Migraine From an Episodic to a Chronic Condition
IRCCS National Neurological Institute "C. Mondino" Foundation·observational·Posted Jan 6, 2021·Updated Jan 6, 2021
In Brief
An observational study for Migraine. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The main aim of the present pilot study is to prove the possibility to use the Nitroglycerin (NTG) model to describe the pathophysiology of headache using task-free advanced Magnetic Resonance Imaging (MRI) techniques, in order to depict the static changes of the ictal and inter-ictal phase of migraine attacks vs the pain free state in healthy subjects and to compare that with the spontaneous headache attack experienced by chronic migraineurs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
Primary CompletionMar 2019
Study CompletionDec 2020
First PostedJan 2021
TodayJul 2026
First PostedJan 6, 2021
Enrollment StartAug 31, 2018
Primary CompletionMar 31, 2019
Study CompletionDec 15, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.5 years ago